Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Enzastaurin with Docetaxel and Prednisone in Prostate Cancer
NCT00466440Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2007
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of enzastaurin in prostate cancer (PCa), sponsored by Eli Lilly and Company. Started Jun 2007; status: completed.
02
Drugs
enzastaurin
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00466440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466440.